Global fund to fight AIDS, tuberculosis and malaria

An international conference calls for substantially increased funding to undertake basic research and start to fight the scourge of AIDS in the developing world.

Written byNancy Heneson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

It's hardly news that the best intentions of governments and the expertise of public health and infectious disease researchers have not succeeded in containing the AIDS epidemic in Africa and other parts of the developing world.

But in April 2001, when UN Secretary General Kofi Annan called for the establishment of a global fund on AIDS and health, hopes rose that the addition of a third critical element — major investment of funds in a coordinated international effort — could promote the integrated goals of controlling HIV and two major related diseases, tuberculosis and malaria.

In October 2001 in Baltimore, Maryland, the Johns Hopkins University Center for AIDS Research hosted a two-day conference that shed some light on whether this hope is warranted. Given that the UN has estimated the cost of preventing and treating AIDS alone in the developing world at 7 to 10 billion dollars annually, and that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies